Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

34.51
Delayed Data
As of Sep 25
 +0.72 / +2.13%
Today’s Change
15.15
Today|||52-Week Range
34.57
+107.02%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash64.8M64.1M68.5M102.4M
 
 
 
 
 
Short Term Investment Cash-39.3M-700.0K4.4M33.9M
 
 
 
 
 
Cash & Short Term Investments186.5M144.8M159.0M150.7M
 
 
 
 
 
 
ReceivablesReceivables85.1M87.7M95.0M111.3M
 
 
 
 
 
 
InventoriesInventories23.9M25.1M38.3M42.2M
 
 
 
 
 
 
Current AssetsPrepaid Expenses20.5M12.5M22.2M12.9M
 
 
 
 
 
Other Current Assets6.4M13.5M0.00--
 
 
 
Current Assets322.4M283.6M314.5M317.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross99.6M138.1M141.7M148.4M
 
 
 
 
 
Depreciation-65.0M-70.9M-83.4M-97.3M
 
 
 
 
 
Intangible Assets374.5M369.8M422.8M807.7M
 
 
 
 
 
Other Assets374.5M369.8M427.8M807.7M
 
 
 
 
 
Total Assets823.8M766.2M943.7M1.3B
 
 
 
 
 
 
LiabilitiesAccounts Payable23.1M21.1M21.1M22.0M
 
 
 
 
 
Accrued Expenses56.4M8.5M9.4M14.1M
 
 
 
 
 
Other Current Liabilities57.5M13.8M13.9M144.0M
 
 
 
 
 
Other Liabilities80.6M68.7M72.3M217.5M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt0.000.000.0099.1M
 
 
Deferred Taxes-3.2M-200.0K-17.9M-84.4M
 
 
 
 
 
Other Liabilities0.003.9M12.3M1.3M
 
 
 
 
Total Liabilities104.8M104.1M195.6M539.9M
 
 
 
 
 
 
EquityMinority Interest0.000.000.00-200.0K
 
 
Preferred Stock0.000.000.000.00--
Common Equity719.0M662.1M748.1M778.2M
 
 
 
 
 
Total Shareholder Equity719.0M662.1M748.1M778.2M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding73.5M68.9M69.1M68.4M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.